Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Edetate calcium disodium

Edetate calcium disodium: 1 brand, 1 generic; first approved May 03, 2023; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 1 ANDA application approved.

Brands (NDA)
1
Generics (ANDA)
1
Listed patents
0
Presentations
3

Brand (NDA) products

Originator applications
  • NDA 0089222 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    200MG/MLINJECTABLEINJECTIONDiscontinued
    500MGTABLETORALDiscontinued

Generic (ANDA) products (1)

Abbreviated applications
  • EDETATE CALCIUM DISODIUMRS
    ANDA 2164352023
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    200MG/MLINJECTABLEINJECTIONRx

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
3 yr 4 mo ago
Most recent approval
3 yr 4 mo ago

All 2 applications were approved in 2023.

Brand (NDA) 150%
Generic (ANDA) 150%

Edetate calcium disodium: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.